UnknownPhase 2

Clinical Trial Using Bone Marrow-derived Mononuclear Cells for Spinal Cord Injury

Vietnam30 participantsStarted 2016-09

Plain-language summary

The purpose of study is to determine whether autologous mononuclear cells deriving from the bone marrow are effective in the treatment of spinal cord injury.

Who can participate

Age range

20 Years – 60 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Patients with spinal cord injuries classified as A-B on the ASIA impairment scale
. Patients injured 3 weeks to 1 year previously
. Patients with partial spinal cord injury demonstrated by diagnostic imaging
. Patients aged between 20 and 60 years at the acquisition of informed consent
. Patients who submitted written informed consent by themselves

Exclusion criteria

. Patients with a completely transected spinal cord
. Patients with central spinal cord injury
. Patients with organ failure with SOFA score of 3 points or higher
. Patients in whom hepatitis B, hepatitis C, human immunodeficiency virus infection, or leukemia infection cannot be denied
. Patients with malignant tumour or a history of malignant tumour within 5 years
. Patients with following disease/disorder:

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Safety profile and adverse effects of the procedure

Timeframe: 6 months from the time when patients receive the treatment

Trial details

NCT IDNCT02923817

SponsorDa Nang Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-12

Contact for this trial

Ba Ngoc Nguyen, MD

+84905238311 ba_neurosur@yahoo.com.vn

View on ClinicalTrials.gov More Spinal Cord Injuries trials